Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Dr. George Wang has over 18 years of drug discovery and antibody engineering experience. He joined WuXi Biologics in 2014 and is currently responsible for protein engineering and bispecific antibody platforms. Dr. Wang received his Ph.D. of Oncology from Peking University and MBA from University of California at Berkeley. He completed his postdoctoral training at Harvard Medical School from1998 to 2001, focusing on implementing bispecific antibodies for HIV research. In the following 13 years Dr. Wang’s focus has been antibody discovery, platform development and global project management at several biotech and pharmaceutical companies including CancerVax/Micromet (acquired by Amgen) and Bayer where he led or contributed to several global biotherapeutic projects that have entered preclinical or clinical development. Dr. Wang has authored over 20 publications in peer-reviewed journals and is the leading inventor of over 30 patents and patent applications.